Multiple rising doses of oral BI 1358894 in healthy male volunteers: a phase I study investigating safety, tolerability and pharmacokinetics

被引：3
|
作者：
Goettel, M. [1 ]
Fuertig, R. [2 ]
Wiebe, S. [2 ]
Herich, L. [3 ]
Sharma, V. [4 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Global Clin Operat, Ingelheim, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, Biberach, Germany
[3] Staburo GmbH, Munich, Germany
[4] Boehringer Ingelheim Pharma GmbH & Co KG, TA CNS Retinopathies Emerging Areas Med, Ingelheim, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 40卷
关键词：
D O I：
10.1016/j.euroneuro.2020.09.330
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.447
引用
收藏
页码：S254 / S255
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults
    Courtney, R
    Pai, S
    Laughlin, M
    Lim, J
    Batra, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2788 - 2795
  • [42] Tolerability and safety of buccal JP-1730. A phase I study in healthy male volunteers
    Peltonen, JM
    Huupponen, R
    Ahokoski, O
    Merivuori, H
    Savola, JM
    Juujarvi, P
    MOVEMENT DISORDERS, 2002, 17 : S100 - S101
  • [43] Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers
    Cho, Yong-Soon
    Lim, Hyeong-Seok
    Cho, Young Lag
    Nam, Hee-Sook
    Bae, Kyun-Seop
    CLINICAL THERAPEUTICS, 2018, 40 (12) : 2050 - 2064
  • [44] Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses
    Wu, Guolan
    Zheng, Yunliang
    Zhou, Huili
    Hu, Xingjiang
    Liu, Jian
    Zhai, You
    Zhu, Meixiang
    Wu, Lihua
    Shentu, Jianzhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5687 - 5695
  • [45] Safety, tolerability, and pharmacokinetics of single and multiple ascending Oral doses of DA-8010 in healthy subjects: First-in-human phase I study
    Lee, Dae Young
    Lee, Min Jung
    Ryu, Chaelim
    Lee, Heewon
    Brooks, Ashley
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [46] Evaluation of safety, tolerability and pharmacokinetics of single escalating oral doses of DPC 333 in healthy volunteers.
    Benedek, IH
    Fossler, M
    Wetherington, J
    Mondick, J
    Davis, C
    Kornhauser, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P61 - P61
  • [47] Safety, Tolerability and Pharmacokinetics of BI 1015550 in Healthy Male Subjects
    Schlecker, C.
    Schultz, A.
    Luedtke, D.
    Coeck, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [48] Safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of the dipeptidyl peptidase 4 inhibitor BI 1356 (proposed tradename ONDERO) in healthy Japanese volunteers
    Sesoko, Shogo
    Nakajima, Mitsuyoshi
    Hayashi, Naoyuki
    Sarashina, Akiko
    Taniguchi, Atushi
    Horie, Yoshiharu
    Dugi, Klaus A.
    DIABETES, 2008, 57 : A159 - A159
  • [49] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE I STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE RISING DOSES 0.5MG TO 500MG OF BI 409306 ADMINISTERED ORALLY IN HEALTHY MALE VOLUNTEERS
    Moschetti, Viktoria
    Boland, Katja
    Feifel, Ulrich
    Hoch, Anja
    Zimdahl-Gelling, Heike
    Sand, Michael
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S325 - S325
  • [50] Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Inhaled Voriconazole in Healthy Volunteers and Subjects With Stable Asthma
    Caponetti, Giovanni
    Sala, Federica
    Cervetti, Antonio
    Colombo, Daniele
    Tiberio, Elena
    Singh, Dave
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2025, 13 (01):
12345